Stock comparison
American Superconductor
AMSC$1.43BIndustrials Market cap, Sector
Mycronic AB (publ)
MYCR.ST$61.28BIndustrials Market cap, Sector
Overall winner
Mycronic AB (publ)
AMSC 16 MYCR.ST
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
AMSC1wins
6winsMYCR.ST
25F
B77
50D
A85
42F
A85
74B
C69
14F
C66
33F
B78
33F
B77
Side-by-side metrics
| Metric | AMSC | MYCR.ST |
|---|---|---|
| Market cap | $1.43B | $61.28B Winner |
| P/E (TTM) | Winner: 18.0x | 37.5x |
| EV/EBIT | Winner: - | 29.1x |
| ROIC (TTM) | 2.27% | 20.79% Winner |
| Gross margin | 30.59% | 52.44% Winner |
| Net margin | Winner: 46.7% | 19.65% |
| Revenue CAGR 5y | Winner: 26.46% | 15.75% |
| EPS CAGR 5y | - | 28.15% |
| Debt / Equity | Winner: 0.0x | 0.0x |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AMSC leads on
- EV/EBIT-vs 29.1x+101%
- Net margin46.7%vs 19.65%+58%
- Debt / Equity0.0xvs 0.0x+57%
- P/E (TTM)18.0xvs 37.5x+52%
MYCR.ST leads on
- Market cap$61.28Bvs $1.43B+98%
- ROIC (TTM)20.79%vs 2.27%+89%
- Gross margin52.44%vs 30.59%+42%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.